Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways
Authors:
Open Access
- 23 June 2016
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 115 (2) , 203-211
Abstract
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.Keywords
This publication has 42 references indexed in Scilit:
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenograftsProceedings of the National Academy of Sciences, 2012
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseNature, 2012
- Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cellsBritish Journal of Cancer, 2012
- Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung TumorsCancer Cell, 2010
- Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS MutationsCancer Research, 2009
- Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in VivoJournal of Medicinal Chemistry, 2009
- A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor GrowthJournal of Medicinal Chemistry, 2008
- Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion KinaseJournal of Biological Chemistry, 2008
- Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung AdenocarcinomasPLOS Medicine, 2007
- Focal adhesion kinase: in command and control of cell motilityNature Reviews Molecular Cell Biology, 2005